nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Dactinomycin—muscle cancer	0.202	0.209	CbGbCtD
Amprenavir—ABCC1—Vincristine—muscle cancer	0.124	0.129	CbGbCtD
Amprenavir—ABCC1—Etoposide—muscle cancer	0.114	0.118	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—muscle cancer	0.0777	0.0805	CbGbCtD
Amprenavir—ABCC1—Methotrexate—muscle cancer	0.0753	0.078	CbGbCtD
Amprenavir—ABCB1—Dactinomycin—muscle cancer	0.0487	0.0505	CbGbCtD
Amprenavir—CYP3A5—Vincristine—muscle cancer	0.0461	0.0478	CbGbCtD
Amprenavir—CYP3A5—Etoposide—muscle cancer	0.0422	0.0438	CbGbCtD
Amprenavir—CYP2C8—Etoposide—muscle cancer	0.0406	0.0421	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—muscle cancer	0.0366	0.0379	CbGbCtD
Amprenavir—ABCB1—Vincristine—muscle cancer	0.03	0.0311	CbGbCtD
Amprenavir—ABCB1—Etoposide—muscle cancer	0.0275	0.0285	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—muscle cancer	0.0187	0.0194	CbGbCtD
Amprenavir—ABCB1—Methotrexate—muscle cancer	0.0182	0.0188	CbGbCtD
Amprenavir—CYP3A4—Vincristine—muscle cancer	0.018	0.0186	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—muscle cancer	0.0177	0.0183	CbGbCtD
Amprenavir—CYP3A4—Etoposide—muscle cancer	0.0165	0.0171	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—muscle cancer	0.0112	0.0116	CbGbCtD
Amprenavir—Opportunistic infection—Methotrexate—muscle cancer	0.000986	0.0282	CcSEcCtD
Amprenavir—Opportunistic infection—Doxorubicin—muscle cancer	0.000854	0.0244	CcSEcCtD
Amprenavir—Myositis—Doxorubicin—muscle cancer	0.000701	0.0201	CcSEcCtD
Amprenavir—Inflammation—Etoposide—muscle cancer	0.000683	0.0196	CcSEcCtD
Amprenavir—Liver function test abnormal—Dactinomycin—muscle cancer	0.000614	0.0176	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.000599	0.0171	CcSEcCtD
Amprenavir—Transaminases increased—Doxorubicin—muscle cancer	0.000565	0.0162	CcSEcCtD
Amprenavir—Neutropenia—Dactinomycin—muscle cancer	0.000537	0.0154	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.000535	0.0153	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.000508	0.0145	CcSEcCtD
Amprenavir—Neutropenia—Vincristine—muscle cancer	0.00048	0.0138	CcSEcCtD
Amprenavir—Depression—Vincristine—muscle cancer	0.000456	0.0131	CcSEcCtD
Amprenavir—Acute coronary syndrome—Vincristine—muscle cancer	0.000451	0.0129	CcSEcCtD
Amprenavir—Myocardial infarction—Vincristine—muscle cancer	0.000449	0.0129	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.000437	0.0125	CcSEcCtD
Amprenavir—Erythema multiforme—Dactinomycin—muscle cancer	0.000435	0.0125	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Etoposide—muscle cancer	0.000424	0.0122	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—muscle cancer	0.000409	0.0117	CcSEcCtD
Amprenavir—Connective tissue disorder—Vincristine—muscle cancer	0.000404	0.0116	CcSEcCtD
Amprenavir—Neutropenia—Etoposide—muscle cancer	0.000389	0.0111	CcSEcCtD
Amprenavir—Cardiac disorder—Vincristine—muscle cancer	0.000381	0.0109	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.000378	0.0108	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000368	0.0105	CcSEcCtD
Amprenavir—Acute coronary syndrome—Etoposide—muscle cancer	0.000366	0.0105	CcSEcCtD
Amprenavir—Myocardial infarction—Etoposide—muscle cancer	0.000363	0.0104	CcSEcCtD
Amprenavir—Mental disorder—Vincristine—muscle cancer	0.00036	0.0103	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—muscle cancer	0.000354	0.0102	CcSEcCtD
Amprenavir—Hepatobiliary disease—Etoposide—muscle cancer	0.000351	0.01	CcSEcCtD
Amprenavir—Myalgia—Dactinomycin—muscle cancer	0.000341	0.00976	CcSEcCtD
Amprenavir—Discomfort—Dactinomycin—muscle cancer	0.000337	0.00965	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—muscle cancer	0.000331	0.00949	CcSEcCtD
Amprenavir—Erythema multiforme—Etoposide—muscle cancer	0.000315	0.00901	CcSEcCtD
Amprenavir—Anorexia—Dactinomycin—muscle cancer	0.000311	0.00892	CcSEcCtD
Amprenavir—Cardiac disorder—Etoposide—muscle cancer	0.000309	0.00885	CcSEcCtD
Amprenavir—Myalgia—Vincristine—muscle cancer	0.000305	0.00872	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000298	0.00853	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—muscle cancer	0.000287	0.00822	CcSEcCtD
Amprenavir—Nervous system disorder—Vincristine—muscle cancer	0.000286	0.0082	CcSEcCtD
Amprenavir—Decreased appetite—Dactinomycin—muscle cancer	0.000284	0.00814	CcSEcCtD
Amprenavir—Fatigue—Dactinomycin—muscle cancer	0.000282	0.00807	CcSEcCtD
Amprenavir—Anorexia—Vincristine—muscle cancer	0.000278	0.00797	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000267	0.00765	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—muscle cancer	0.000266	0.00762	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000266	0.00762	CcSEcCtD
Amprenavir—Paraesthesia—Vincristine—muscle cancer	0.000262	0.00751	CcSEcCtD
Amprenavir—Abdominal pain—Dactinomycin—muscle cancer	0.000258	0.0074	CcSEcCtD
Amprenavir—Decreased appetite—Vincristine—muscle cancer	0.000254	0.00727	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vincristine—muscle cancer	0.000252	0.00722	CcSEcCtD
Amprenavir—Fatigue—Vincristine—muscle cancer	0.000252	0.00721	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000245	0.00702	CcSEcCtD
Amprenavir—Discomfort—Etoposide—muscle cancer	0.000244	0.00698	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—muscle cancer	0.000239	0.00684	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vincristine—muscle cancer	0.000239	0.00684	CcSEcCtD
Amprenavir—Asthenia—Dactinomycin—muscle cancer	0.000234	0.00672	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—muscle cancer	0.000233	0.00667	CcSEcCtD
Amprenavir—Abdominal pain—Vincristine—muscle cancer	0.000231	0.00661	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—muscle cancer	0.00023	0.0066	CcSEcCtD
Amprenavir—Skin disorder—Etoposide—muscle cancer	0.00023	0.00658	CcSEcCtD
Amprenavir—Anorexia—Etoposide—muscle cancer	0.000225	0.00646	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000225	0.00644	CcSEcCtD
Amprenavir—Diarrhoea—Dactinomycin—muscle cancer	0.000224	0.0064	CcSEcCtD
Amprenavir—Depression—Methotrexate—muscle cancer	0.000221	0.00634	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00022	0.00631	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00022	0.0063	CcSEcCtD
Amprenavir—Paraesthesia—Etoposide—muscle cancer	0.000212	0.00608	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—muscle cancer	0.00021	0.00602	CcSEcCtD
Amprenavir—Asthenia—Vincristine—muscle cancer	0.000209	0.006	CcSEcCtD
Amprenavir—Vomiting—Dactinomycin—muscle cancer	0.000208	0.00595	CcSEcCtD
Amprenavir—Rash—Dactinomycin—muscle cancer	0.000206	0.0059	CcSEcCtD
Amprenavir—Decreased appetite—Etoposide—muscle cancer	0.000206	0.00589	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Etoposide—muscle cancer	0.000204	0.00585	CcSEcCtD
Amprenavir—Fatigue—Etoposide—muscle cancer	0.000204	0.00584	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—muscle cancer	0.000202	0.00578	CcSEcCtD
Amprenavir—Diarrhoea—Vincristine—muscle cancer	0.0002	0.00572	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—muscle cancer	0.000195	0.00557	CcSEcCtD
Amprenavir—Nausea—Dactinomycin—muscle cancer	0.000194	0.00556	CcSEcCtD
Amprenavir—Gastrointestinal pain—Etoposide—muscle cancer	0.000193	0.00554	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000191	0.00546	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—muscle cancer	0.000189	0.0054	CcSEcCtD
Amprenavir—Abdominal pain—Etoposide—muscle cancer	0.000187	0.00535	CcSEcCtD
Amprenavir—Vomiting—Vincristine—muscle cancer	0.000186	0.00532	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—muscle cancer	0.000185	0.0053	CcSEcCtD
Amprenavir—Rash—Vincristine—muscle cancer	0.000184	0.00527	CcSEcCtD
Amprenavir—Dermatitis—Vincristine—muscle cancer	0.000184	0.00527	CcSEcCtD
Amprenavir—Headache—Vincristine—muscle cancer	0.000183	0.00524	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000182	0.00521	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—muscle cancer	0.000175	0.005	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—muscle cancer	0.000174	0.00497	CcSEcCtD
Amprenavir—Nausea—Vincristine—muscle cancer	0.000173	0.00497	CcSEcCtD
Amprenavir—Asthenia—Etoposide—muscle cancer	0.00017	0.00486	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—muscle cancer	0.00017	0.00486	CcSEcCtD
Amprenavir—Pruritus—Etoposide—muscle cancer	0.000167	0.00479	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—muscle cancer	0.000163	0.00468	CcSEcCtD
Amprenavir—Diarrhoea—Etoposide—muscle cancer	0.000162	0.00463	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—muscle cancer	0.00016	0.00459	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—muscle cancer	0.000151	0.00433	CcSEcCtD
Amprenavir—Vomiting—Etoposide—muscle cancer	0.00015	0.00431	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—muscle cancer	0.00015	0.0043	CcSEcCtD
Amprenavir—Rash—Etoposide—muscle cancer	0.000149	0.00427	CcSEcCtD
Amprenavir—Dermatitis—Etoposide—muscle cancer	0.000149	0.00427	CcSEcCtD
Amprenavir—Headache—Etoposide—muscle cancer	0.000148	0.00424	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—muscle cancer	0.000148	0.00424	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—muscle cancer	0.000148	0.00423	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000147	0.0042	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—muscle cancer	0.000146	0.00418	CcSEcCtD
Amprenavir—Nausea—Etoposide—muscle cancer	0.00014	0.00402	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—muscle cancer	0.000139	0.00398	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—muscle cancer	0.000138	0.00394	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—muscle cancer	0.000135	0.00387	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000129	0.0037	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—muscle cancer	0.000128	0.00366	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—muscle cancer	0.000127	0.00364	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000127	0.00364	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—muscle cancer	0.000126	0.00362	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—muscle cancer	0.000123	0.00353	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000122	0.0035	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—muscle cancer	0.000122	0.0035	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—muscle cancer	0.00012	0.00345	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—muscle cancer	0.000119	0.00341	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—muscle cancer	0.000117	0.00335	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000116	0.00332	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—muscle cancer	0.000112	0.00321	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000112	0.0032	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—muscle cancer	0.00011	0.00315	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—muscle cancer	0.000107	0.00305	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000106	0.00303	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—muscle cancer	0.000106	0.00303	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—muscle cancer	0.000102	0.00291	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0001	0.00287	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—muscle cancer	0.0001	0.00287	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—muscle cancer	9.7e-05	0.00278	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—muscle cancer	9.69e-05	0.00278	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—muscle cancer	9.01e-05	0.00258	CcSEcCtD
Amprenavir—Rash—Methotrexate—muscle cancer	8.93e-05	0.00256	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—muscle cancer	8.92e-05	0.00256	CcSEcCtD
Amprenavir—Headache—Methotrexate—muscle cancer	8.87e-05	0.00254	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—muscle cancer	8.8e-05	0.00252	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—muscle cancer	8.68e-05	0.00249	CcSEcCtD
Amprenavir—Nausea—Methotrexate—muscle cancer	8.41e-05	0.00241	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—muscle cancer	8.39e-05	0.0024	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—muscle cancer	7.8e-05	0.00223	CcSEcCtD
Amprenavir—Rash—Doxorubicin—muscle cancer	7.73e-05	0.00222	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—muscle cancer	7.73e-05	0.00221	CcSEcCtD
Amprenavir—Headache—Doxorubicin—muscle cancer	7.68e-05	0.0022	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—muscle cancer	7.29e-05	0.00209	CcSEcCtD
